The chemo-gut study: investigating the long-term effects of chemotherapy on gut microbiota, metabolic, immune, psychological and cognitive parameters in young adult Cancer survivors; study protocol
| dc.contributor.author | Deleemans, Julie M | |
| dc.contributor.author | Chleilat, Faye | |
| dc.contributor.author | Reimer, Raylene A | |
| dc.contributor.author | Henning, Jan-Willem | |
| dc.contributor.author | Baydoun, Mohamad | |
| dc.contributor.author | Piedalue, Katherine-Ann | |
| dc.contributor.author | McLennan, Andrew | |
| dc.contributor.author | Carlson, Linda E | |
| dc.date.accessioned | 2019-12-29T01:05:00Z | |
| dc.date.available | 2019-12-29T01:05:00Z | |
| dc.date.issued | 2019-12-23 | |
| dc.date.updated | 2019-12-29T01:04:58Z | |
| dc.description.abstract | Abstract Background The gut microbiota is an important modulator of immune, metabolic, psychological and cognitive mechanisms. Chemotherapy adversely affects the gut microbiota, inducing acute dysbiosis, and alters physiological and psychological function. Cancer among young adults has risen 38% in recent decades. Understanding chemotherapy’s long-term effects on gut microbiota and psycho-physiological function is critical to improve survivors’ physical and mental health, but remains unexamined. Restoration of the gut microbiota via targeted therapies (e.g. probiotics) could potentially prevent or reverse the psycho-physiological deficits often found in young survivors following chemotherapy, ultimately leading to reduced symptom burden and improved health. Methods This longitudinal study investigates chemotherapy induced long-term gut dysbiosis, and associations between gut microbiota, and immune, metabolic, cognitive and psychological parameters using data collected at < 2 month (T1), 3–4 months (T2), and 5–6 months (T3) post-chemotherapy. Participants will be 18–39 year old blood or solid tumor cancer survivors (n = 50), and a healthy sibling, partner or friend as a control (n = 50). Gut microbiota composition will be measured from fecal samples using 16 s RNA sequencing. Psychological and cognitive patient reported outcome measures will include depression, anxiety, post-traumatic stress disorder symptoms, pain, fatigue, and social and cognitive function. Dual-energy X-ray Absorptiometry (DXA) will be used to measure fat and lean mass, and bone mineral concentration. Pro-inflammatory cytokines, C-reactive protein (CRP), lipopolysaccharide (LPS), serotonin, and brain derived neurotrophic factor (BDNF) will be measured in serum, and long-term cortisol will be assayed from hair. Regression and linear mixed model (LMM) analyses will examine associations across time points (T1 – T3), between groups, and covariates with gut microbiota, cognitive, psychological, and physiological parameters. Conclusion Knowing what bacterial species are depleted after chemotherapy, how long these effects last, and the physiological mechanisms that may drive psychological and cognitive issues among survivors will allow for targeted, integrative interventions to be developed, helping to prevent or reverse some of the late-effects of treatment that many young cancer survivors face. This protocol has been approved by the Health Research Ethics Board of Alberta Cancer Committee (ID: HREBA.CC-19-0018). | |
| dc.identifier.citation | BMC Cancer. 2019 Dec 23;19(1):1243 | |
| dc.identifier.doi | https://doi.org/10.1186/s12885-019-6473-8 | |
| dc.identifier.uri | http://hdl.handle.net/1880/111394 | |
| dc.identifier.uri | https://doi.org/10.11575/PRISM/45353 | |
| dc.language.rfc3066 | en | |
| dc.rights.holder | The Author(s). | |
| dc.title | The chemo-gut study: investigating the long-term effects of chemotherapy on gut microbiota, metabolic, immune, psychological and cognitive parameters in young adult Cancer survivors; study protocol | |
| dc.type | Journal Article |